MannKind | MNKD - PE Price to Earnings


MannKind reported 303.7 in PE Price to Earnings for its fiscal quarter ending in December of 2025.





Pe Change Date
Adma Biologics 29.73 12.48 Dec/2025
BioCryst Pharmaceuticals 6.06 1.07K Dec/2025
Eli Lilly 40.21 9.66 Dec/2025
Halozyme Therapeutics 23.16 7.7 Dec/2025
MannKind 303.7 273.14 Dec/2025
Merck 13.92 5.08 Dec/2025
Novavax 2.01 1.07 Dec/2025
Novo Nordisk 13.92 4.91 Sep/2025
Pfizer 14.48 5.18 Dec/2025
Sanofi 11.99 1.58 Dec/2025
Xencor 29.92 3.22 Sep/2022